Literature DB >> 19432535

Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression.

Jose F Camargo1, Hemant Kulkarni, Brian K Agan, Alvaro A Gaitan, Lisa A Beachy, Sowmya Srinivas, Weijing He, Stephanie Anderson, Vincent C Marconi, Matthew J Dolan, Sunil K Ahuja.   

Abstract

BACKGROUND: Despite suppression of the human immunodeficiency virus type 1 (HIV-1) load by highly active antiretroviral therapy (HAART), recovery of CD4+ T cell counts can be impaired. We investigated whether this impairment may be associated with hyporesponsiveness of T cells to gamma-chain (gammac) cytokines known to influence T cell homeostasis.
METHODS: The responsiveness of T cells to interleukin (IL)-2, IL-7, and IL-15 was determined by assessing cytokine-induced phosphorylation of the signal transducer and activator of transcription 5 (STAT5) in peripheral T cells obtained from 118 HIV-positive subjects and 13 HIV-negative subjects.
RESULTS: The responsiveness of T cells to interleukin (IL)-7 but not to IL-2 or IL-15 was lower among HIV-positive subjects than among HIV-negative subjects. Among subjects with viral load suppression, the degree of IL-7 responsiveness (1) correlated with naive CD4+ T cell counts and was a better immune correlate of the prevailing CD4+ T cell count than were levels of human leukocyte antigen-DR1 or programmed death-1, which are predictors of T cell homeostasis during HIV infection; and (2) was greater in subjects with complete (i.e., attainment of >or=500 CD4+ T cells/mm3>or=5 years after initiation of HAART) versus incomplete immunologic responses. The correlation between plasma levels of IL-7 and CD4+ T cell counts during HAART was maximal in subjects with increased IL-7 responsiveness.
CONCLUSIONS: Responsiveness of T cells to IL-7 is associated with higher CD4+ T cell counts during HAART and thus may be a determinant of the extent of immune reconstitution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19432535      PMCID: PMC3777824          DOI: 10.1086/598858

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  IL-7 is critical for homeostatic proliferation and survival of naive T cells.

Authors:  J T Tan; E Dudl; E LeRoy; R Murray; J Sprent; K I Weinberg; C D Surh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function.

Authors:  L Teixeira; H Valdez; J M McCune; R A Koup; A D Badley; M K Hellerstein; L A Napolitano; D C Douek; G Mbisa; S Deeks; J M Harris; J D Barbour; B H Gross; I R Francis; R Halvorsen; R Asaad; M M Lederman
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

Review 3.  Lymphocide: cytokines and the control of lymphoid homeostasis.

Authors:  Annette R Khaled; Scott K Durum
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

Review 4.  T cell dynamics in HIV-1 infection.

Authors:  Daniel C Douek; Louis J Picker; Richard A Koup
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

5.  Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages.

Authors:  James J Kohler; Daniel L Tuttle; Carter R Coberley; John W Sleasman; Maureen M Goodenow
Journal:  J Leukoc Biol       Date:  2003-03       Impact factor: 4.962

6.  Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection.

Authors:  Alain Gervaix; Joelle Nicolas; Pierre Portales; Klara Posfay-Barbe; Claire-Anne Wyler; Michel Segondy; Odile Avinens; Claire-Anne Siegrist; Jacques Clot; Jean-François Eliaou; Jacques Astruc; Pierre Corbeau
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

7.  A potential role for interleukin-7 in T-cell homeostasis.

Authors:  T J Fry; E Connick; J Falloon; M M Lederman; D J Liewehr; J Spritzler; S M Steinberg; L V Wood; R Yarchoan; J Zuckerman; A Landay; C L Mackall
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

8.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks
Journal:  J Infect Dis       Date:  2003-04-23       Impact factor: 5.226

9.  Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study.

Authors:  E Florence; J Lundgren; C Dreezen; M Fisher; O Kirk; A Blaxhult; G Panos; C Katlama; S Vella; A Phillips
Journal:  HIV Med       Date:  2003-07       Impact factor: 3.180

10.  Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells.

Authors:  Benedict Seddon; Peter Tomlinson; Rose Zamoyska
Journal:  Nat Immunol       Date:  2003-06-15       Impact factor: 25.606

View more
  23 in total

1.  Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance.

Authors:  Jessica N Hodge; Sharat Srinivasula; Zonghui Hu; Sarah W Read; Brian O Porter; Insook Kim; Joann M Mican; Chang Paik; Paula Degrange; Michele Di Mascio; Irini Sereti
Journal:  Blood       Date:  2011-07-21       Impact factor: 22.113

2.  Interleukin-7 enhances memory CD8(+) T-cell recall responses in health but its activity is impaired in human immunodeficiency virus infection.

Authors:  Alison M O'Connor; Angela M Crawley; Jonathan B Angel
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

Review 3.  Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup.

Authors:  Vasudha Sundaravaradan; Kiran D Mir; Donald L Sodora
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

4.  Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.

Authors:  M Cecilia Albareda; Damián Perez-Mazliah; M Ailén Natale; Melisa Castro-Eiro; María G Alvarez; Rodolfo Viotti; Graciela Bertocchi; Bruno Lococo; Rick L Tarleton; Susana A Laucella
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

5.  Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients.

Authors:  J F Suarez; R Rosa; M A Lorio; M I Morris; L M Abbo; J Simkins; G Guerra; D Roth; W L Kupin; A Mattiazzi; G Ciancio; L J Chen; G W Burke; M J Goldstein; P Ruiz; J F Camargo
Journal:  Am J Transplant       Date:  2016-04-04       Impact factor: 8.086

Review 6.  Residual inflammation and viral reservoirs: alliance against an HIV cure.

Authors:  Marta Massanella; Rémi Fromentin; Nicolas Chomont
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

Review 7.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

8.  Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner.

Authors:  Rajeev Mehla; Shalmali Bivalkar-Mehla; Ruonan Zhang; Indhira Handy; Helmut Albrecht; Shailendra Giri; Prakash Nagarkatti; Mitzi Nagarkatti; Ashok Chauhan
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

Review 9.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 10.  Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs.

Authors:  Eleanor M P Wilson; Irini Sereti
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.